Advertisement

Related Videos

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Peter Clark, MA, MD, FRCP: A Payer Perspective

Advertisement

Advertisement




Mar
19
Today In Oncology
Timely Scans May Reduce Mortality in Patients Who Present to the ER With Hematuria
PSMA PET-CT Scan Reduces Need for Prostate Cancer Biopsies
New AACR President-Elect and Board Members Announced
Activity Observed With Novel KRAS Inhibitor in Pancreatic Cancer (1)
Neoadjuvant/Adjuvant Doublet Significantly Improved Survival in Patients With Muscle-Invasive Bladder Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo